Biomarkers to aid diagnosis of irregular heart beat identified

IANS  |  London 

Researchers have identified two that could help in the diagnosis of a irregular heart beat condition that raises the risk of

But it is often detected only after someone has had a

The study, by researchers at the in the UK, found three clinical risk factors and two had a strong connection with AF, the reported on Monday.

Those most at risk of the condition were older, male and had a high BMI.

One is a hormone secreted by the heart called brain natriuretic peptide (BNP) and the other is a protein responsible for phosphate regulation called fibroblast growth factor-23 (FGF-23).

"The we have identified have the potential to be used in a blood test in community settings such as in general practices to simplify patient selection for ECG screening," was quoted as saying.

The researchers said that these people could be screened for the condition by testing their blood to see if they have elevated levels of the two biomarkers.

According to the British Heart Foundation, the study could pave the way towards better detection of people with AF and targeted treatment.

"People with are much more likely to develop and suffer from To avoid it is important for them to take anticoagulant drugs to prevent blood clotting. However, is often only diagnosed after a patient has suffered a stroke," said co-from the varsity.

"Therefore it is important that patients at risk are screened so that they can begin taking anticoagulants to prevent potentially life-threatening complications," Chua noted.

Currently, an electrocardiogram (ECG) which measures the electrical activity of your heart, is usually used to screen patients for AF.

For the study, the researchers looked at 638 hospital patients who were recruited between 2014 and 2016 for acute illnesses, the report said.

--IANS

rt/ksk/vm

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Mon, January 07 2019. 13:42 IST